Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metformin for Treatment of Psoriasis Combined With Disorders of Glucose and Lipid Metabolism: A Double-Blind, Randomized, Placebo-Controlled Study

NCT03629639 is registered in ClinicalTrials.gov with Central South University as lead sponsor.

NCT NCT03629639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03629639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metformin for Treatment of Psoriasis Combined With Disorders of Glucose and Lipid Metabolism: A Double-Blind, Randomized, Placebo-Controlled Study
Lead sponsor
Central South University
Phase
Phase 4
Overall status
Unknown status
Start date
September 1, 2018
Completion date
December 1, 2020
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis vulgaris with metabolic disorders